# Prozac Treatment of Major Depression: Discontinuation Study

> **NCT00427128** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 627 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** fluoxetine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00427128
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-11
- **Primary completion:** —
- **Final completion:** 2003-03
- **Target enrollment:** 627 (ACTUAL)
- **Last updated:** 2011-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427128, "Prozac Treatment of Major Depression: Discontinuation Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00427128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*